The jury decision closes the courthouse door. The IRS is still open.
A nine-person jury in Oakland ruled last week that Elon Musk waited too long to sue OpenAI and Sam Altman. The verdict was unanimous. Deliberations took less than two hours. Judge Yvonne Gonzalez Rogers accepted it as her own. That's the legal result.
The public-policy result is harder to read—and considerably more consequential.
Musk donated approximately $44 million to OpenAI between 2015 and 2017, backing a nonprofit research lab whose founding charter stated its assets were "irrevocably dedicated" to ensuring artificial general intelligence would benefit humanity—not private shareholders. Greg Brockman's 2017 diary captured the insider view: "I cannot believe that we committed to non-profit if three months later we're doing B-Corp then it was a lie." The jury never ruled on whether he was right. It ruled on when Musk filed his lawsuit.
OpenAI completed its conversion to a public benefit corporation in October 2025. The OpenAI Foundation now holds a 26% equity stake valued at roughly $130 billion. Microsoft holds approximately 27%. The company's valuation sits at $852 billion and is heading toward a near-trillion-dollar IPO. Those returns originated inside a tax-exempt charitable structure.
Section 501(c)(3) organizations are prohibited from operating for the benefit of private interests, and the IRS private inurement rules are explicit: no part of a nonprofit's net earnings may flow to private individuals. These aren't guidelines, they're the conditions under which the federal government grants tax-exempt status. The public, through foregone tax revenues, subsidized OpenAI's mission. The question of whether that mission was honored is a tax-law question, not a tort question. It doesn't require Musk to have standing. It requires the IRS to act.
California Attorney General Rob Bonta signed off on the conversion last October. The settlement was later described by legal experts as "full of holes." The public record shows that OpenAI's legal defense in the Bonta investigation was led by a former Newsom chief of staff; Altman has donated over $1 million to California Democrats, including state-level figures in Bonta's political network; and the resulting deal contained significant board overlap between the nonprofit and the for-profit it nominally controls. No documented direct Altman-to-Bonta contribution appears in public campaign finance records. But the political architecture around the settlement deserves congressional scrutiny—particularly from members who have oversight of both the IRS and federal charitable trust enforcement.
This isn't a new problem. The healthcare industry ran this script for thirty years. There were 29 nonprofit hospital conversions in 1986 alone. Blue Cross of California—the legal precedent critics cited in opposing OpenAI's deal—made this same journey. Consumers Union documented the pattern: community assets transferred to insiders, weakened public access, and regulators who arrived after the fact. Today's verdict, decided on a technicality, just cleared the primary legal obstacle to anyone who wants to run the same play in technology. Oren Etzioni of the Allen Institute for AI named the forward risk plainly: if this conversion stands without IRS challenge, "American charity law is a tax-advantaged staging ground for whichever venture later proves lucrative."
The answer isn't to prohibit nonprofits from evolving. The rules already allow conversion—provided assets are preserved at fair value and oversight is genuine. What's missing is oversight that precedes the transaction: independent boards, mandatory disclosure when a nonprofit's stated mission and its economic incentives diverge, and federal enforcement authority applied before the IPO runway is clear.
Two legal scholars who testified at trial—Daniel Hemel of NYU and John Coates of Harvard—said they saw no legal problem with OpenAI's structure. That may be true. But "legally permissible" and "faithful to donor intent" are different standards. One is a floor. The other is what the donors were actually promised. The jury was never allowed to rule on whether OpenAI met either one. And the IRS doesn't need a plaintiff—it has independent enforcement authority that the statute of limitations ruling left entirely intact.
Congress has jurisdiction here on two tracks: oversight of the IRS and oversight of federal charitable enforcement. Members on both sides of the aisle have legitimate reasons to care about whether tax-exempt status is being used as a subsidized staging ground for commercial ventures that benefit insiders. The healthcare industry ran this script for thirty years and communities paid for it. If Congress waits until the IPO to act, the moment will have passed.
The Musk verdict is a legal answer to a legal question. Whether OpenAI's donors funded a public good or underwrote one of the largest private wealth transfers in technology history wasn't answered in Oakland. The IRS has not weighed in. Congress has said nothing. That's not mission drift. That's mission laundering—and the public's right to ask who approved it has no statute of limitations.
Jay Rogers is a financial professional with more than 30 years of experience in private equity, private credit, hedge funds, and wealth management. He has a BS from Northeastern University and has completed postgraduate studies at UCLA, UPENN, and Harvard. He writes about issues in finance, constitutional law, national security, human nature, and public policy.